Eur Rev Med Pharmacol Sci 2021; 25 (21): 6444-6444

DOI: 10.26355/eurrev_202111_27133

Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A

W.-G. Bian, X.-N. Zhou, S. Song, H.-T. Chen, Y. Shen, P. Chen

Department of Oncology, Yancheng City No. 1 People’s Hospital, Yancheng, China.


The article “Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A”, W.-G. Bian, X.-N. Zhou, S. Song, H.-T. Chen, Y. Shen, P. Chen, published in Eur Rev Med Pharmacol Sci 2019; 23 (2): 649-659–DOI: 10.26355/eurrev_201901_16879–PMID: 30720173, has been retracted by the authors due to several inaccuracies in the research design.

The Publisher apologizes for any inconvenience this may cause.

Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A

Free PDF Download

To cite this article

W.-G. Bian, X.-N. Zhou, S. Song, H.-T. Chen, Y. Shen, P. Chen
Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 21
Pages: 6444-6444
DOI: 10.26355/eurrev_202111_27133